Arrowhead Pharmaceuticals Inc (ARWR)
Return on equity (ROE)
| Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net income (ttm) | US$ in thousands | -1,631 | -148,417 | -143,969 | -639,714 | -599,493 | -538,636 | -470,789 | -296,814 | -205,275 | -181,107 | -150,207 | -154,516 | -176,063 | -153,926 | -111,804 | -182,988 | -140,848 | -125,907 | -109,594 | -102,612 |
| Total stockholders’ equity | US$ in thousands | 466,052 | 519,806 | 683,321 | 52,589 | 185,444 | 330,547 | 483,794 | 160,407 | 271,343 | 364,830 | 446,772 | 377,039 | 105,960 | 453,927 | 452,266 | 372,560 | 408,822 | 436,890 | 445,549 | 454,472 |
| ROE | -0.35% | -28.55% | -21.07% | -1,216.44% | -323.27% | -162.95% | -97.31% | -185.04% | -75.65% | -49.64% | -33.62% | -40.98% | -166.16% | -33.91% | -24.72% | -49.12% | -34.45% | -28.82% | -24.60% | -22.58% |
September 30, 2025 calculation
ROE = Net income (ttm) ÷ Total stockholders’ equity
= $-1,631K ÷ $466,052K
= -0.35%